| Hormones, Menopause, Andropause, and Endocrinology Journal Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Treatment Options for Male Hypogonadism
Biundo Bruce
|
Jan/Feb 2024
Pg. 6-14
|
The Physiologic Role and Use of Estriol
Paoletti Jim E
|
Jan/Feb 2024
Pg. 16-21
|
Establishing a Rationale for Compounding Hormone Replacement Therapy
Biundo Bruce
|
Jan/Feb 2024
Pg. 22-27
|
Hormone Treatment Options for Males: What to do for Men with Low Testosterone
Biundo Bruce
|
Jan/Feb 2024
Pg. 28-32
|
Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 58
|
Major Study Affirming the Relative Safety of Testosterone-replacement Therapy
Biundo Bruce
|
Sep/Oct 2023
Pg. 358-360
|
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study
Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
|
Mar/Apr 2023
Pg. 108-112
|
Diazoxide 10-mg/mL in Oral Mix SF
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 510
|
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates)
Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
|
Mar/Apr 2022
Pg. 150-154
|
Kayexalate in Lactulose
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 501
|
Clonidine 0.01-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 414
|
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 416
|
Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application
Polonini Hudson, de Oliveira Ferreira Anderson, Dijkers Eli
|
Sep/Oct 2021
Pg. 422-426
|
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
|
Sep/Oct 2021
Pg. 431-439
|
Hydrocortisone 2-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 325
|
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 327
|
The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report
McKettrick Greg, Yoch Doug
|
Mar/Apr 2021
Pg. 94-98
|
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension
McElhiney Linda F
|
Jan/Feb 2021
Pg. 24-28
|
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 31-38
|
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1
DeRosa Angela
|
Nov/Dec 2020
Pg. 466-470
|
Prednisolone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 229
|
Sildenafil 2.5 mg/mL in Methylcellulose 1%:Syrup (1:1) Oral Suspension
Allen Loyd V Jr
|
May/Jun 2020
Pg. 230
|
Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 131
|
Propylthiouracil 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 135
|
Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 62
|
Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution
Marotta James C, Patel Gopesh, Carvalho Maria, Blakeney Samantha
|
Jan/Feb 2020
Pg. 69-76
|
Calculations
Stockton Shelly J, Stover Emily M
|
Nov/Dec 2019
Pg. 484
|
Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 492
|
Domperidone 5 mg/mL in Oral Mix
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 316
|
Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy
Glaser Rebecca L, York Anne E
|
Jul/Aug 2019
Pg. 325-339
|
Development and Validation of a Stability-indicating High-performance Liquid Chromatographic Method for Quantification of Progesterone in Compounded Glycerinated Gelatin Troches
Burrows Anna C, Yellepeddi Venkata Kashyap, Snyder Spencer, Wakefield Meagan, Jackson David, Huynh Johnny, Nguyen Khoa, Sayre Casey L
|
Jul/Aug 2019
Pg. 340-350
|
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)
Riepl Mike
|
May/Jun 2019
Pg. 192-199
|
Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet
Allen Loyd V Jr
|
May/Jun 2019
Pg. 236
|
Magnesium Sulfate and Lidocaine Hydrochloride Injection in Prefilled Syringes
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 55
|
Methimazole 5 mg/0.1 mL in Pluronic Lecithin Organogel Gel, Veterinary
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 56
|
Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets
Sayre Casey L, Cox Christopher, Velazquez Gabriel, Le Minh Thi, Nguyen Amy Hong, Ramos Marjorie, Burrows Anna, Yellepeddi Venkata Kashyap
|
Jan/Feb 2019
Pg. 62-64
|
Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle
Polonini Hudson, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
|
Jan/Feb 2019
Pg. 65-69
|
Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy
Laque Larissa C, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C
|
Jan/Feb 2019
Pg. 77-81
|
Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome
Riepl Mike
|
Nov/Dec 2018
Pg. 456-465
|
Case Study: Absorption of Testosterone Cream via Scrotal Delivery
Needham Shawn, Needham Shane
|
Nov/Dec 2018
Pg. 466-468
|
Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase)
Ip Kendice, Shan Ashley, Yan Wei, Banov Daniel
|
Nov/Dec 2018
Pg. 504-511
|
Cysteamine 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 408
|
Prolonged In-use Stability of Reconstituted Herceptin in Commercial Intravenous Bags
Nalenz Heiko, Köpf Ellen, Dietel Elke
|
Sep/Oct 2018
Pg. 417-423
|
Cinacalcet 5-mg/mL in Oral-Plus/Ora-Sweet Suspension
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 318
|
Establishing a Rationale for Compounding Hormone Replacement Therapy
Biundo Bruce
|
May/Jun 2018
Pg. 190-195
|
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy
Rhoads Rick
|
Mar/Apr 2018
Pg. 129-134
|
Trilostane 5-mg/mL in Cod Liver Oil Suspension (Vet)
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 153
|
The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions
Svirskis Darren, Lin Shao-Wei, Brown Helen, Sangaroomthong Annie, Shin Daniel, Wang Ziqi, Xu Hongtao, Dean Rebecca, Vareed Preetika, Jensen Maree, Wu Zimei
|
Mar/Apr 2018
Pg. 164-171
|
PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 444
|
Compounding Opportunities in Urology
Biundo Bruce
|
Sep/Oct 2017
Pg. 358-362
|
Fluoxymesterone 10-mg Capsules
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 412
|
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
|
Sep/Oct 2017
Pg. 418-425
|
Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases
Allen Loyd V Jr
|
May/Jun 2017
Pg. 238
|
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Deleruyelle Laura J
|
Jan/Feb 2017
Pg. 6-16
|
A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding
Rush Steven D, Vernak Charlene, Zhao Fang
|
Jan/Feb 2017
Pg. 83-87
|
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Deleruyelle Laura J
|
Nov/Dec 2016
Pg. 447-454
|
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy
Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
|
Nov/Dec 2016
Pg. 461-467
|
Alendronate 70-mg/75-mL Drinkable Formulation
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 504
|
Melatonin 2-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 512
|
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Deleruyelle Laura J
|
Sep/Oct 2016
Pg. 359-364
|
Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 407
|
Progesterone 10% Cream
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 412
|
Nystatin 100,000-units Vaginal Inserts
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 322
|
Estradiol Valerate 40-mg/mL in Oil Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 509
|
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules
Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
|
Sep/Oct 2015
Pg. 414-419
|
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures
Nahata Milap C
|
Sep/Oct 2015
Pg. 428-431
|
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity
Biundo Bruce, Gogola Margaret
|
Jul/Aug 2015
Pg. 289-293
|
Oxytocin 10-units/mL Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 330
|
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy
Guth Michael AS
|
May/Jun 2015
Pg. 195-203
|
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Jan/Feb 2015
Pg. 6-12
|
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Heustess Allie, Asbill Scott, Eagerton David, Arnold John
|
Nov/Dec 2014
Pg. 512-515
|
Calcitriol 1-mcg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 324
|
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
|
Jul/Aug 2014
Pg. 332-340
|
Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation
Phan Ha, DeReese Annie, Day A J, Carvalho Maria
|
May/Jun 2014
Pg. 203-207
|
Tamoxifen 10-mg or 20-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 240
|
Mecasermin 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 144
|
Methylprednisolone 40-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 145
|
Secretin 4 mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 148
|
Testosterone Enanthate 200-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 151
|
The Standardization of Nonsterile Compounding: A Study in Quality Control and Assessment for Hormone Compounding
Wiley TS, Odegard RD, Raden J, Haraldsen JT
|
Mar/Apr 2014
Pg. 162-168
|
The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study
Ruiz Andres D, Daniels Kelly R
|
Jan/Feb 2014
Pg. 70-77
|
Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy
Fichter Brian, Heintzelman Tom, Hurst Sawan, Fitzsimmons Dorothy, Mailloux Christina
|
Nov/Dec 2013
Pg. 452-457
|
Cortisone Acetate 25-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 501
|
Hydrocortisone 50-mg/mL Injection (as the Sodium Succinate)
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 504
|
Levothyroxine Sodium 100-mcg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 505
|
Allopurinol Sodium 4-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 328
|
Calcium Acetate 667-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 229
|
Estradiol 0.5-mg, 1-mg, or 2-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 230
|
Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities
Zur Eyal
|
Mar/Apr 2013
Pg. 113-123
|
Treatment Options for Male Hypogonadism
Biundo Bruce
|
Jan/Feb 2013
Pg. 28-38
|
Adrenal Fatigue
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 39-44
|
Desmopressin 4-mcg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 64
|
Milrinone 0.2-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 69
|
Octreotide 50-mcg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 72
|
Testosterone Cypionate 100-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 73
|
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
|
Jan/Feb 2013
Pg. 74-85
View Sample |
Medical Therapy for Acquired Urinary Incontinence in Dogs
Hill Katie, Jordan Dinah, Ray Jody, Mays Andrew A, Griffin Katie
|
Sep/Oct 2012
Pg. 369-375
|
Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol
Snyder Scott, Listecki Robert E
|
Sep/Oct 2012
Pg. 376-380
|
PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone
Cabaleiro Joe
|
Jan/Feb 2012
Pg. 86-87
|
A Retrospective Observational Case Series Analysis of the Usage of Hydroxyprogesterone Caproate for the Prevention of Preterm Labor in Alabama Patients
Nolan Sara M, Burgess Christopher A
|
Nov/Dec 2011
Pg. 446-448
|
Citric Acid, Potassium Citrate, and Sodium Citrate Solution
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 335
|
PreScription: Two Lessons in 17-Hydroxyprogesterone
Menighan Thomas E
|
Jul/Aug 2011
Pg. 268
|
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review
Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
|
Jul/Aug 2011
Pg. 290-300
|
Oxandrolone 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 341
|
Testosterone Levels in an Aging Population: Screen, Measure, and Restore
Kells John, DollbaumCharles M
|
Mar/Apr 2011
Pg. 102-112
|
The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women
Bramwell Bethany L
|
Nov/Dec 2010
Pg. 465-471
|
Bioidentical Hormones in the News
Bramwell Bethany L
|
Sep/Oct 2010
Pg. 374-380
|
Thyroid Potency Calculations
Stack Bob
|
Jul/Aug 2010
Pg. 306-309
|
The Role of Sex Hormones on Fibromyalgia Pain Mediators
Bramwell Bethany L
|
May/Jun 2010
Pg. 193-199
|
PreScription: The Ages of Man
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 92
|
Emerging Evidence for Androgen Replacement Therapy in Aging Men
Bramwell Bethany L
|
Mar/Apr 2010
Pg. 94-99
|
Hormonal Influences in Prostate Cancer: An Update of a Complex Subject
Biundo Bruce
|
Mar/Apr 2010
Pg. 100-104
|
Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword?
Williams LaVonn A
|
Mar/Apr 2010
Pg. 105-107
|
Calculations
Stockton Shelly J
|
Mar/Apr 2010
Pg. 140-141
|
Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study
Moro Doris, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah
|
Mar/Apr 2010
Pg. 165-170
|
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet
McElhiney Linda F, Cheng Angela, Meshberger Laura, Imai Lara
|
Jan/Feb 2010
Pg. 21-25
|
Testosterone 1% in Alcoholic Gel
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 72
|
Sleepless in America: Compounding with Melatonin
Wynn Tom, Rawlings Kate
|
Jan/Feb 2010
Pg. 10-13
|
Chemical Stability of Hydrocortisone in Humco Simple Syrup and Ora-Sweet Vehicle
Gupta Vishnu D
|
Jan/Feb 2010
Pg. 76-77
|
Low Testosterone in Older Men: A Discussion and Review of Literature on Health Consequences of Hypogonadism in the Aging Male
Biundo Bruce
|
Nov/Dec 2009
Pg. 494-496
|
Gentian Violet Vaginal Suppositories
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 556
|
Urinary Deoxypyridinoline Level Reveals Bone Resorption, Predicts Fracture Risk, and Enhances the Results of Dual Energy X-Ray Absorptiometry
Kells John, Dollbaum Charles M
|
Nov/Dec 2009
Pg. 516-524
|
Lubow's Solution
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 558
|
Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing
Kells John, Dollbaum Charles M
|
Sep/Oct 2009
Pg. 392-399
|
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding
Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
|
Jul/Aug 2009
Pg. 314-317
|
Mupirocin 1% (20-mg) Vaginal Suppository
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 338
|
Quality of Progesterone Suppositories Prepared by FIRST-Progesterone VGS 50 Kit or Traditional Compounding Method: In Vitro Comparison
Chauhan Harsh, Atef Eman
|
Jul/Aug 2009
Pg. 342-344
|
Women's Perspective on Progesterone: A Qualitative Study Conducted in Australia
Spark M Joy, Dunn Rebecca A, Houlahan Kelli L
|
Jul/Aug 2009
Pg. 345-349
|
The Physiologic Role and Use of Estriol
Paoletti Jim E
|
Jul/Aug 2009
Pg. 270-275
|
Hormone Treatment Options for Males: What to Do for Men with Low Testosterone
Biundo Bruce
|
Jul/Aug 2009
Pg. 276-279
|
Saliva Tests, Part 1: Clinical Use, Elements of Testing, and Guidelines for Posttreatment Interpretation
Kells John, Dollbaum Charles M
|
Jul/Aug 2009
Pg. 280-288
|
Calculations
Stockton Shelly J
|
Jul/Aug 2009
Pg. 330
|
Clindamycin 100-mg Vaginal Suppositories
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 334
|
Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 450
|
Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 546
|
Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism
Paoletti Jim
|
Nov/Dec 2008
Pg. 488-497
|
Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 545
|
Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 547
|
Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 548
|
PreScription: First Estriol, Then What?
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 284
|
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
|
Jul/Aug 2008
Pg. 295-304
|
Progesterone and Traumatic Brain Injury: A Review of Literature
Williams LaVonn A, Mead Jay H
|
Jul/Aug 2008
Pg. 310-315
|
Lubricating Gel
Allen Loyd V Jr
|
May/Jun 2008
Pg. 263
|
Hormone Therapy: It's Time for a Second Opinion
Collins Joseph J, Ahlgrimm Maria
|
Mar/Apr 2008
Pg. 122-127
|
Aminacrine Hydrochloride 0.1% Cream
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 148
|
EDTA 1% Cream
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 152
|
Equine Cushing's Disease: A Clinical Update
Bliss George
|
Sep/Oct 2007
Pg. 384-388
|
Ergonovine Maleate 0.2-mg/mL Injection, Veterinary
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 422
|
Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature
Paoletti Jim, Kaul Monica, Kloesel Lawson G
|
Jul/Aug 2007
Pg. 269-272
|
The History of Progesterone
Newton Stephen J
|
Jul/Aug 2007
Pg. 274-277
|
Premarin: The Intriguing History of a Controversial Drug
Vance Dwight A
|
Jul/Aug 2007
Pg. 282-286
|
Common Acronyms Used by Health Professionals Who Prescribe or Prepare Hormone Replacement
Price Dared L
|
Jul/Aug 2007
Pg. 288-291
|
The Lived Experience of Perimenopausal and Menopausal Women Undergoing Treatment with Bioidentical Hormones
Holt-Waldo NaRisa Y, Stephenson Kenna
|
Jul/Aug 2007
Pg. 292-296
|
Calculations
Stockton Shelly J
|
Jul/Aug 2007
Pg. 324
|
Cholecalciferol 40,000-IU/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 243
|
Levothyroxine Sodium 40-micro-g/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 247
|
Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes
Fields Shannon W
|
Mar/Apr 2007
Pg. 122-124
|
Case Report: Treatment of Labial Adhesions in a Child
Fields Shannon W
|
Jan/Feb 2007
Pg. 27
|
Dexamethasone 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 72
|
Prednisone 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 77
|
Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 78
|
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate
Reed-Kane Dana, Kirshbaum Karen
|
May/Jun 2006
Pg. 165-171
|
Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor
Fields Shannon W
|
May/Jun 2006
Pg. 172
|
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States
Stephenson Kenna, Jones William, Stephenson Douglas M M
|
May/Jun 2006
Pg. 175-183
|
Extended Stability of Oxytocin in Common Infusion Solutions
Trissel Lawrence A, Zhang Yanping, Douglass Kate, Kastango Eric
|
Mar/Apr 2006
Pg. 156-158
|
Misoprostol 1-mg Suppository
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 65
|
Propylthiouracil 5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 67
|
Book Reviews: Awakening Athena: Resilience, Restoration, and Rejuvenation for Women
Reed-Kane Dana, Grajeda Betty Jo
|
Jul/Aug 2005
Pg. 252
|
Book Reviews: Perfect Balance
Reed-Kane Dana, Grajeda Betty Jo
|
Jul/Aug 2005
Pg. 253-254
|
Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome
Tan Robert S
|
Jul/Aug 2005
Pg. 259-264
View Sample |
Hypothyroidism: Optimizing Therapy with Slow-Release Compounded Thyroid Replacement
Milner Martin
|
Jul/Aug 2005
Pg. 268-273
|
Compounding for Endocrine Disorders in Adult Patients
Grajeda Betty Jo, Vail Jane
|
Jul/Aug 2005
Pg. 275-278
|
Calculations
Prince Shelly J
|
Jul/Aug 2005
Pg. 307-308
|
PostScription: Women in Balance: A Cause Worth Advancing
Murray Jane, Reilly Colleen
|
Jul/Aug 2005
Pg. 327-328
|
Methimazole 10-mg/mL Oral Liquid, Veterinary
Allen Loyd V Jr
|
May/Jun 2005
Pg. 229
|
Pergolide 500-mcg Capsules, Veterinary
Allen Loyd V Jr
|
May/Jun 2005
Pg. 231
|
Pergolide 0.2-mg/mL Oral Liquid, Veterinary
Allen Loyd V Jr
|
May/Jun 2005
Pg. 232
|
Book Review: The Medical & Surgical Practice of NaProTECHNOLOGY
Reed-Kane Dana
|
Jan/Feb 2005
Pg. 5-6
|
Amitriptyline Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2005
Pg. 62
|
Chemical Stability of Metoclopramide Hydrochloride Injection Diluted with 0.9% Sodium Chloride Injection in Polypropylene Syringes at Room Temperature
Gupta Vishnu D
|
Jan/Feb 2005
Pg. 72-74
|
Stability of an Extemporaneously Compounded Propylthiouracil Suspension
Alexander Kenneth S, Mitra Pallabi
|
Jan/Feb 2005
Pg. 82-86
|
| Return to Top |
